Three interconnected projects represent the most significant modernisation of genomic medicine infrastructure in the NHS's history. The move from paper-based processes to fully integrated digital workflows will create new market opportunities while requiring substantial adaptation from existing suppliers.
Sign up for free
Create a free account to access this content and stay up to date with the latest insights.
Sign up



